TARGAN

Based in Raleigh, North Carolina, TARGAN, a wholly owned subsidiary of Intervet, Inc., d/b/a Merck Animal Health, is a global AgTech business dedicated to advancing animal health, productivity, and sustainability across the poultry and other livestock industries. As global demand for animal protein continues to grow, TARGAN leverages high-speed imaging, artificial intelligence, machine learning, and robotics to help producers improve efficiency and sustainable food production. Learn more at TARGAN.com.

About Merck Animal Health

Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is a global animal health business committed to The Science of Healthier Animals™. For more than 130 years, we have pioneered groundbreaking science. Today, we are driven by continuous innovation to develop breakthrough medicines, vaccines and technology. Rooted in direct experience on the farm and in the clinic, we work hand in hand with our customers every step of the way. Our singular focus is to empower those who care for animals, helping them manage their vital responsibility with confidence. Because when it comes to animal health, no one sees it like we do. For more information, visit www.merck-animal-health.com and connect with us on LinkedIn, Facebook, X (formerly Twitter) and Instagram.

AER THERAPEUTICS, INC

Aer Therapeutics is a clinical-stage biopharmaceutical company developing a novel inhaled therapy for respiratory diseases marked by excess mucus, including COPD, cystic fibrosis, and asthma, with technology originating from research at UCSF, University College Dublin, and Trinity College Dublin. Having raised over $48 million in financing, the company has advanced its lead candidate, AER-01, through Phase 1 and into an ongoing Phase 2a COPD trial, with topline data expected by end of Q3 2026.

CALIDAR

Calidar, Inc. is a RTP-based medtech company developing the world's first clinical application of volumetric X-ray diffraction imaging for breast cancer diagnostics. Its 4D Mammography system reads the molecular fingerprint of breast tissue — delivering new diagnostic information that today's 3D imaging cannot provide. Calidar's technology is designed to reduce unnecessary biopsies, improve diagnostic accuracy, and enable earlier detection at the point of imaging. 

DG MATRIX

 DG Matrix is the global leader in solid-state transformer solutions, building the intelligent power fabric of the AI datacenter to remove stranded power as AI's binding constraint. Its Interport™ platform, built on the world's first programmable multi-port solid-state transformer, converts and routes power between the grid, generation, storage, and compute loads, helping operators bring AI capacity online in months instead of years.

FILETAX.COM

FileTax.com makes tax filing simple and honestly priced for the 95% of Americans who don't have a CPA. Ten profitable years, 2.3 million users, entirely self-funded. 

INCYCLIX BIO

Incyclix Bio is a next-generation cell cycle control company founded by pioneers in CDK inhibitor discovery, advancing precision treatments that target the aberrant proliferation driving cancers such as ovarian, breast, and lung. A scientific leader in understanding CDKs as therapeutic targets across many tumor types, the company's lead compound, a potent and selective CDK2 inhibitor, is nearing clinical stage.

PATHALYS

Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.

RESTOR3D

restor3d is a leader in patient-specific, 3D-printed musculoskeletal implants, holding proprietary expertise in 3D printing of osseointegrative materials, AI-based planning and design automation, and digital health solutions. The company combines these capabilities to deliver data-backed, personalized care aimed at optimizing individual patient outcomes and reshaping the musculoskeletal reconstruction landscape.

SIFTWELL

Siftwell Analytics is an applied analytics platform for community-oriented health plans. It turns data into tactical intelligence, helping teams identify rising-risk members and the next best action to improve their health. Using population stratification, psychographic profiling, machine learning, and causal inference, it guides frontline teams on who to reach and how, turning insight into results in weeks, not quarters.

TREECO

TreeCo is a Raleigh-based NC State spinout and one of few R&D engines applying CRISPR to commercial forestry, using AI-powered biodesign and transgene-free genome editing to produce more productive, climate-resilient trees for the $800 billion forestry industry. With over 10,000 genetically enhanced trees and 20+ edited lines in field trials, the company is advancing toward commercial deployment through a partnership with a major global forestry products company.